Jianmin Pharmaceutical Group Co (SHSE:600976) Valuation Rank

View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Jianmin Pharmaceutical Group Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Jianmin Pharmaceutical Group Co (SHSE:600976) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Valuation Rank

Traded in Other Exchanges

N/A

Address

No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052

Website

http://www.whjm.com

Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.